Figure S2. Downregulation of MHC Class I on CD11b+Gr-1+ Cells from Anti-Pd-1 Resistant Tumors. from Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy